tiprankstipranks
Advertisement
Advertisement
Touchlight Highlights Cell-Free DNA as Emerging Infrastructure for Advanced Therapies
PremiumPrivate CompaniesTouchlight Highlights Cell-Free DNA as Emerging Infrastructure for Advanced Therapies
3d ago
Touchlight Amplifies Cost and Performance Case for Cell-Free DNA Platforms
Premium
Private Companies
Touchlight Amplifies Cost and Performance Case for Cell-Free DNA Platforms
5d ago
Touchlight Highlights Enzymatic Circular DNA Platform for Next-Generation Gene Editing
Premium
Private Companies
Touchlight Highlights Enzymatic Circular DNA Platform for Next-Generation Gene Editing
6d ago
Cost Efficiency Emerges as Key Focus in AAV Gene Therapy Manufacturing
PremiumPrivate CompaniesCost Efficiency Emerges as Key Focus in AAV Gene Therapy Manufacturing
9d ago
Cell-Free DNA Platforms Positioned as Infrastructure for Gene and Viral Therapies
Premium
Private Companies
Cell-Free DNA Platforms Positioned as Infrastructure for Gene and Viral Therapies
10d ago
Touchlight Highlights Data Indicating Efficiency Gains in Lentiviral Vector Production
Premium
Private Companies
Touchlight Highlights Data Indicating Efficiency Gains in Lentiviral Vector Production
10d ago
Touchlight Targets Business Development Opportunities at BIO International 2026
PremiumPrivate CompaniesTouchlight Targets Business Development Opportunities at BIO International 2026
15d ago
Touchlight Highlights mbDNA Platform for Non-Viral Gene Editing in HSPCs
Premium
Private Companies
Touchlight Highlights mbDNA Platform for Non-Viral Gene Editing in HSPCs
16d ago
Touchlight Positions dbDNA™ Platform as Scalable Alternative for Genetic Medicine Manufacturing
Premium
Private Companies
Touchlight Positions dbDNA™ Platform as Scalable Alternative for Genetic Medicine Manufacturing
17d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100